...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ASCO study...Celgene
3
Jun 01, 2019 02:30PM
2
Jun 01, 2019 05:48PM
Share
New Message
Please login to post a reply